FI853056A0 - Process for the preparation of polypeptide with hirudin activity - Google Patents
Process for the preparation of polypeptide with hirudin activityInfo
- Publication number
- FI853056A0 FI853056A0 FI853056A FI853056A FI853056A0 FI 853056 A0 FI853056 A0 FI 853056A0 FI 853056 A FI853056 A FI 853056A FI 853056 A FI853056 A FI 853056A FI 853056 A0 FI853056 A0 FI 853056A0
- Authority
- FI
- Finland
- Prior art keywords
- polypeptide
- preparation
- sequences
- incorporated
- hirudin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Seal Device For Vehicle (AREA)
- Extrusion Moulding Of Plastics Or The Like (AREA)
- Luminescent Compositions (AREA)
Abstract
Hirudin can be obtained using a specific DNA sequence in a genetic engineering process. The gene is advantageously synthesised in the form of several fragments which are enzymatically ligated to give two larger part-sequences which are incorporated into hybrid plasmids and amplified in host organisms. The part-sequences are reisolated and then combined to form the complete gene which is incorporated into a hybrid plasmid and the latter is expressed in a host organism. <IMAGE>
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19843429430 DE3429430A1 (en) | 1984-08-10 | 1984-08-10 | GENE TECHNOLOGICAL METHOD FOR PRODUCING HIRUDINE AND MEANS FOR IMPLEMENTING THIS METHOD |
DE3429430 | 1984-08-10 |
Publications (4)
Publication Number | Publication Date |
---|---|
FI853056A0 true FI853056A0 (en) | 1985-08-08 |
FI853056L FI853056L (en) | 1986-02-11 |
FI91883B FI91883B (en) | 1994-05-13 |
FI91883C FI91883C (en) | 1994-08-25 |
Family
ID=6242746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI853056A FI91883C (en) | 1984-08-10 | 1985-08-08 | Process for the preparation of polypeptide with hirudin activity |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0171024B1 (en) |
JP (1) | JPH0811073B2 (en) |
KR (1) | KR930009337B1 (en) |
AT (1) | ATE67245T1 (en) |
AU (1) | AU584628B2 (en) |
CA (1) | CA1341124C (en) |
DE (2) | DE3429430A1 (en) |
DK (1) | DK175337B1 (en) |
ES (1) | ES8605040A1 (en) |
FI (1) | FI91883C (en) |
GR (1) | GR851962B (en) |
HU (1) | HU206135B (en) |
IE (1) | IE58485B1 (en) |
IL (1) | IL76059A (en) |
NO (1) | NO177434C (en) |
NZ (1) | NZ213049A (en) |
PT (1) | PT80930B (en) |
ZA (1) | ZA856026B (en) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3438296A1 (en) * | 1984-04-18 | 1985-11-07 | Hoechst Ag, 6230 Frankfurt | NEW POLYPEPTIDES WITH A BLOOD-CLOTHING EFFECT, METHOD FOR THE PRODUCTION OR THEIR RECOVERY, THEIR USE AND THE CONTAINERS THEREOF |
DE3445517C2 (en) * | 1984-12-13 | 1993-11-18 | Ciba Geigy | DNA sequence coding for a hirudin-like protein and method for producing a hirudin-like protein |
DE3738541A1 (en) * | 1987-11-13 | 1989-05-24 | Hoechst Ag | METHOD FOR INSULATING AND CLEANING HIRUDINE |
FR2593518B1 (en) * | 1985-05-02 | 1989-09-08 | Transgene Sa | VECTORS FOR THE EXPRESSION AND SECRETION OF HIRUDIN BY TRANSFORMED YEASTS |
DE3689525D1 (en) * | 1985-07-17 | 1994-02-24 | Hoechst Ag | New polypeptides with an anticoagulant effect, processes for their preparation or extraction, their use and agents containing them. |
DE3541856A1 (en) * | 1985-11-27 | 1987-06-04 | Hoechst Ag | EUKARYOTIC FUSION PROTEINS, THEIR PRODUCTION AND USE, AND MEANS FOR CARRYING OUT THE PROCESS |
MY101203A (en) * | 1985-12-12 | 1991-08-17 | Ucp Gen Pharma Ag | Production of thrombin iinhibitors. |
GB8530631D0 (en) | 1985-12-12 | 1986-01-22 | Ciba Geigy Ag | Thrombin inhibitors |
GB2188322A (en) * | 1986-03-26 | 1987-09-30 | Bayer Ag | Aprotinin and analogues thereof produced by a recombinant host |
GB2188933A (en) * | 1986-04-10 | 1987-10-14 | Bayer Ag | Expression vectors for production of polypeptides, method for enhanced expression of polypeptides, hosts containing the expression vectors, products manufactured thereby |
FR2607516B2 (en) * | 1986-12-01 | 1989-12-22 | Transgene Sa | IMPROVED VECTORS FOR EXPRESSING A HIRUDIN VARIANT IN YEAST, PROCESS AND PRODUCT OBTAINED |
MC1834A1 (en) * | 1986-07-10 | 1988-06-03 | Transgene Sa | DNA FUNCTIONAL BLOCK AND PLASMID ENCODING HIRUDINE, TRANSFORMED YEAST, PROCESS FOR PREPARING HIRUDINE, HIRUDINE OBTAINED AND ITS USE |
FR2607517B2 (en) * | 1986-12-01 | 1989-12-22 | Transgene Sa | VECTORS FOR EXPRESSING HIRUDIN VARIANTS IN YEAST, PROCESS AND PRODUCT OBTAINED |
GB2199582A (en) * | 1987-01-07 | 1988-07-13 | Bayer Ag | Analogues of pancreatic secretory trypsin inhibitor |
US5032573A (en) * | 1987-03-23 | 1991-07-16 | Bayer Aktiengesellschaft | Homologs of aprotinin produced from a recombinant host, process, expression vector and recombinant host therefor and pharmaceutical use thereof |
US5236898A (en) * | 1987-05-21 | 1993-08-17 | Merrell Dow Pharmaceuticals Inc. | Cyclic anticoagulant peptides |
US5192745A (en) * | 1987-05-21 | 1993-03-09 | Merrell Dow Pharmaceuticals Inc. | Cyclic anticoagulant peptides |
GB8723662D0 (en) * | 1987-10-08 | 1987-11-11 | British Bio Technology | Synthetic gene |
GB8723661D0 (en) * | 1987-10-08 | 1987-11-11 | British Bio Technology | Synthetic gene |
US5256559A (en) * | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
FR2628429B1 (en) * | 1988-03-08 | 1990-12-28 | Transgene Sa | HIRUDINE VARIANTS, USES THEREOF AND PROCESSES FOR OBTAINING THEM |
DE3819079A1 (en) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | HIRUDINE DERIVATIVES WITH DELAYED EFFECT |
US5112615A (en) * | 1988-08-03 | 1992-05-12 | New England Deaconess Hospital Corporation | Soluble hirudin conjugates |
US5167960A (en) * | 1988-08-03 | 1992-12-01 | New England Deaconess Hospital Corporation | Hirudin-coated biocompatible substance |
DE3835815A1 (en) * | 1988-10-21 | 1990-04-26 | Hoechst Ag | NEW ISOHIRUDINE |
US5192747A (en) * | 1989-10-03 | 1993-03-09 | Merrell Dow Pharmaceuticals Inc. | Anticoagulant peptides |
DE4009268A1 (en) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | SECRETION OF HIRUDIN DERIVATIVES |
GB9010552D0 (en) * | 1990-05-10 | 1990-07-04 | Erba Carlo Spa | Method for the recombinant production of hirudins and novel hirudins |
US6514730B1 (en) | 1991-03-21 | 2003-02-04 | Consortium für elektrochemische Industrie GmbH | Secretion of hirudin derivatives |
DE4140381A1 (en) * | 1991-12-07 | 1993-06-09 | Hoechst Ag, 6230 Frankfurt, De | NEW SYNTHETIC ISOHIRUDINE WITH IMPROVED STABILITY |
US5972648A (en) * | 1993-09-28 | 1999-10-26 | Japan Energy Corporation | Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients |
DE4404168A1 (en) * | 1994-02-10 | 1995-08-17 | Hoechst Ag | Hirudin derivatives and process for their preparation |
DE19529997C1 (en) | 1995-08-16 | 1997-04-10 | Hoechst Ag | A method for inactivating carboxypeptidase Y in hirudin-containing culture broths |
DE19543737A1 (en) * | 1995-11-24 | 1997-05-28 | Hoechst Ag | Process for the ultrafiltration of biological matrices containing peptides or proteins |
DE19544233A1 (en) | 1995-11-28 | 1997-06-05 | Hoechst Ag | Process for using the yeast ADH II promoter system for the biotechnological production of heterologous proteins in high yields |
DE19607239A1 (en) | 1996-02-27 | 1997-08-28 | Behringwerke Ag | Pharmaceutical composition containing hirudin and process for its preparation |
DE19944870A1 (en) * | 1999-09-18 | 2001-03-29 | Aventis Pharma Gmbh | Signal sequences for the production of Leu-hirudin via secretion by E. coli in the culture medium |
DE10149678A1 (en) | 2001-10-09 | 2009-03-12 | Novel Science International Gmbh | New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
DE10301255A1 (en) | 2003-01-15 | 2004-07-29 | Cpi Creative Pharma International Gmbh | Organic compounds with biological action as thrombin inhibitors and their use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK339781A (en) * | 1980-08-05 | 1982-02-06 | Searle & Co | SYNTHETIC GEN |
DE3342139A1 (en) * | 1983-11-22 | 1985-05-30 | Ciba-Geigy Ag, Basel | DESULFATOHIRUDINE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS |
CA1341417C (en) * | 1984-03-27 | 2003-01-21 | Paul Tolstoshev | Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
EP0168342B1 (en) * | 1984-06-14 | 1991-07-03 | Ciba-Geigy Ag | Process for the preparation of thrombin inhibitors |
-
1984
- 1984-08-10 DE DE19843429430 patent/DE3429430A1/en not_active Withdrawn
-
1985
- 1985-07-09 IL IL76059A patent/IL76059A/en not_active IP Right Cessation
- 1985-07-30 EP EP85109567A patent/EP0171024B1/en not_active Expired - Lifetime
- 1985-07-30 AT AT85109567T patent/ATE67245T1/en not_active IP Right Cessation
- 1985-07-30 DE DE8585109567T patent/DE3584053D1/en not_active Expired - Lifetime
- 1985-08-05 HU HU852980A patent/HU206135B/en unknown
- 1985-08-08 ES ES545994A patent/ES8605040A1/en not_active Expired
- 1985-08-08 FI FI853056A patent/FI91883C/en not_active IP Right Cessation
- 1985-08-08 NZ NZ213049A patent/NZ213049A/en unknown
- 1985-08-09 JP JP60174404A patent/JPH0811073B2/en not_active Expired - Lifetime
- 1985-08-09 PT PT80930A patent/PT80930B/en unknown
- 1985-08-09 ZA ZA856026A patent/ZA856026B/en unknown
- 1985-08-09 CA CA000488468A patent/CA1341124C/en not_active Expired - Fee Related
- 1985-08-09 IE IE197385A patent/IE58485B1/en not_active IP Right Cessation
- 1985-08-09 GR GR851962A patent/GR851962B/el unknown
- 1985-08-09 DK DK198503645A patent/DK175337B1/en not_active IP Right Cessation
- 1985-08-09 NO NO853155A patent/NO177434C/en not_active IP Right Cessation
- 1985-08-09 AU AU45977/85A patent/AU584628B2/en not_active Expired
- 1985-08-10 KR KR1019850005776A patent/KR930009337B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO853155L (en) | 1986-02-11 |
NO177434B (en) | 1995-06-06 |
HU206135B (en) | 1992-08-28 |
AU4597785A (en) | 1986-02-13 |
ES8605040A1 (en) | 1986-02-16 |
NO177434C (en) | 1995-09-13 |
EP0171024B1 (en) | 1991-09-11 |
IE58485B1 (en) | 1993-09-22 |
PT80930B (en) | 1987-11-11 |
DK175337B1 (en) | 2004-08-30 |
FI853056L (en) | 1986-02-11 |
IL76059A0 (en) | 1985-12-31 |
IL76059A (en) | 1993-08-18 |
FI91883B (en) | 1994-05-13 |
KR930009337B1 (en) | 1993-09-27 |
IE851973L (en) | 1986-02-10 |
CA1341124C (en) | 2000-10-24 |
KR870002257A (en) | 1987-03-30 |
DE3584053D1 (en) | 1991-10-17 |
JPS6147198A (en) | 1986-03-07 |
DE3429430A1 (en) | 1986-02-20 |
HUT38968A (en) | 1986-07-28 |
ATE67245T1 (en) | 1991-09-15 |
EP0171024A1 (en) | 1986-02-12 |
DK364585A (en) | 1986-02-11 |
JPH0811073B2 (en) | 1996-02-07 |
ES545994A0 (en) | 1986-02-16 |
AU584628B2 (en) | 1989-06-01 |
DK364585D0 (en) | 1985-08-09 |
NZ213049A (en) | 1988-05-30 |
PT80930A (en) | 1985-09-01 |
ZA856026B (en) | 1986-03-26 |
FI91883C (en) | 1994-08-25 |
GR851962B (en) | 1985-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI853056A0 (en) | Process for the preparation of polypeptide with hirudin activity | |
NO172646C (en) | DNA SEQUENCE, REPLICABLE EXPRESSION PLASMID, AND MANUFACTURE OF INSULIN AND HUMAN-INSULIN PROCEDURES | |
ES2000278A6 (en) | Fusion proteins, method for their production and their use. | |
NO171983C (en) | PREPARATION OF POLYPEPTIDES WITH HUMAN-GAMMA INTERFERON ACTIVITY AND DNA SEQUENCE thereof | |
GR851291B (en) | ||
ES8603571A1 (en) | Gene-technologic process for the preparation of human gamma-interferon, and means for carrying out this process. | |
IE872531L (en) | Preparation of salmon calcitonin by genetic engineering, and¹means for carrying out this process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
FG | Patent granted |
Owner name: SCHERING AKTIENGESELLSCHAFT |
|
MA | Patent expired |